Reaction
Oesophageal Haemorrhage reporting signals
As of the last recalculation, Oesophageal Haemorrhage appears in 1,307 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is GRANISETRON (PRR 21.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Granisetron | 14 | 21.5 | 21.5 |
| Granisetron Hydrochloride | 13 | 20.0 | 20.0 |
| Tranexamic Acid | 9 | 16.2 | 16.2 |
| Rifaximin | 16 | 12.3 | 12.3 |
| Lenvatinib | 18 | 8.8 | 8.9 |
| Cisplatin | 38 | 7.9 | 8.0 |
| Sunitinib Malate | 19 | 7.8 | 7.8 |
| Sorafenib | 10 | 7.7 | 7.7 |
| Rivaroxaban | 90 | 7.3 | 7.3 |
| Glecaprevir And Pibrentasvir | 5 | 7.3 | 7.3 |
| Atezolizumab | 17 | 7.1 | 7.1 |
| Oxaliplatin | 29 | 6.3 | 6.3 |
| Prasugrel Hydrochloride | 4 | 6.3 | 6.3 |
| Velpatasvir And Sofosbuvir | 5 | 6.2 | 6.2 |
| Dabigatran Etexilate | 28 | 5.8 | 5.8 |
| Sofosbuvir | 7 | 5.7 | 5.7 |
| Eltrombopag Olamine | 8 | 5.6 | 5.6 |
| Dabigatran Etexilate Mesylate | 23 | 5.1 | 5.1 |
| Trifluridine And Tipiracil | 3 | 4.5 | 4.5 |
| Ledipasvir And Sofosbuvir | 5 | 4.2 | 4.2 |
| Emicizumab | 3 | 3.9 | 3.9 |
| Valbenazine | 3 | 1.9 | 1.9 |